• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA-DRw52相关决定簇在DRβ1分子上的定位

Mapping of an HLA-DRw52-associated determinant on DR beta 1 molecules.

作者信息

Ballas M, Eiermann T H, Wölpl A, Goldmann S F

机构信息

Department of Transplantation Immunology, Red Cross Blood Bank Ulm, Germany.

出版信息

Tissue Antigens. 1990 Nov;36(5):187-93. doi: 10.1111/j.1399-0039.1990.tb01828.x.

DOI:10.1111/j.1399-0039.1990.tb01828.x
PMID:1710076
Abstract

The molecular reaction patterns of the DRw52-specific mouse monoclonal antibodies UL-52 and 7.3.19.1 were investigated. Upon immunoprecipitation and two-dimensional IEF-SDS polyacrylamide gel electrophoresis analysis (2D-PAGE) mAb UL-52 selectively isolated DR beta 1 molecules from DRw52-positive cell lines, whereas mAb 7.3.19.1 predominantly precipitated DR beta 3 molecules. Reduced mAb UL-52 binding affinity was observed to DRw8- and DRw12-positive cells, potentially resulting from structural modifications within the antibody binding site. Comparison of mAb UL-52 reactivity with published DR beta chain amino acid sequences demonstrates that the amino acid residues -S- in positions 11 and 13 on DR beta 1 molecules essentially contribute to the formation of the antibody binding site. mAb 7.3.19.1 reactivity, on the other hand, correlates with the expression of DR beta 3 chain amino acid residues K, G and N, in positions 71, 73 and 77, respectively. In contrast to other DRw52 monoclonal antibodies described so far, mAb UL-52 demonstrates a similar reactivity to DRw52 allosera, suggesting that mAb UL-52 and DRw52 allosera possibly recognize the same or a similar determinant on DR beta 1 molecules.

摘要

研究了DRw52特异性小鼠单克隆抗体UL-52和7.3.19.1的分子反应模式。经免疫沉淀和二维IEF-SDS聚丙烯酰胺凝胶电泳分析(2D-PAGE),单克隆抗体UL-52从DRw52阳性细胞系中选择性分离出DRβ1分子,而单克隆抗体7.3.19.1主要沉淀出DRβ3分子。观察到单克隆抗体UL-52与DRw8和DRw12阳性细胞的结合亲和力降低,这可能是由于抗体结合位点内的结构修饰所致。将单克隆抗体UL-52的反应性与已发表的DRβ链氨基酸序列进行比较表明,DRβ1分子第11和13位的氨基酸残基-S-基本上有助于抗体结合位点的形成。另一方面,单克隆抗体7.3.19.1的反应性分别与DRβ3链第71、73和77位的氨基酸残基K、G和N的表达相关。与迄今为止描述的其他DRw52单克隆抗体不同,单克隆抗体UL-52对DRw52同种血清表现出相似的反应性,这表明单克隆抗体UL-52和DRw52同种血清可能识别DRβ1分子上相同或相似的决定簇。

相似文献

1
Mapping of an HLA-DRw52-associated determinant on DR beta 1 molecules.HLA-DRw52相关决定簇在DRβ1分子上的定位
Tissue Antigens. 1990 Nov;36(5):187-93. doi: 10.1111/j.1399-0039.1990.tb01828.x.
2
Monoclonal antibody to a supertypic determinant associated with HLA-DRw52.
Hybridoma. 1989 Aug;8(4):467-74. doi: 10.1089/hyb.1989.8.467.
3
Functional polymorphism of each of the two HLA-DR beta chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T cell clones.利用抗原特异性DR3和DRw52限制性T细胞克隆证明了两个HLA - DRβ链基因座各自的功能多态性。
J Exp Med. 1988 Mar 1;167(3):853-72. doi: 10.1084/jem.167.3.853.
4
Major histocompatibility complex class II-restricted antigen presentation across a species barrier: conservation of restriction determinants in evolution.主要组织相容性复合体II类限制的跨物种屏障抗原呈递:进化中限制决定簇的保守性
J Exp Med. 1990 Jul 1;172(1):53-9. doi: 10.1084/jem.172.1.53.
5
Ia molecular localization of the DRw52 allodeterminant and the DRw52-like determinants defined by monoclonal antibodies.DRw52同种异体决定簇及由单克隆抗体所定义的DRw52样决定簇的Ia分子定位。
J Immunol. 1985 Oct;135(4):2642-6.
6
Epitope mapping of an HLA-DR-specific monoclonal antibody produced by using human-mouse transfectant cells.
J Immunol. 1989 Dec 15;143(12):4084-9.
7
Monoclonal antibody definition of the DRB3 allele, HLA-Dw25.
Tissue Antigens. 1989 Sep;34(3):149-57. doi: 10.1111/j.1399-0039.1989.tb01730.x.
8
Identification of HLA-DR1 beta chain residues critical for binding staphylococcal enterotoxins A and E.鉴定对结合葡萄球菌肠毒素A和E至关重要的HLA - DR1β链残基。
J Exp Med. 1992 Feb 1;175(2):415-24. doi: 10.1084/jem.175.2.415.
9
Functional polymorphism of the HLA-DR beta III chain.
Hum Immunol. 1988 Jan;21(1):49-61. doi: 10.1016/0198-8859(88)90080-8.
10
Recognition of HLA-DR1/DRB1*0101 molecules presenting HLA-A2 derived peptides by a human recombinant antibody, Fab-5 A1.人重组抗体Fab-5 A1对呈递HLA-A2衍生肽的HLA-DR1/DRB1*0101分子的识别
Eur J Immunogenet. 1998 Oct;25(5):339-47. doi: 10.1046/j.1365-2370.1998.00120.x.

引用本文的文献

1
HLA Mismatching Strategies for Solid Organ Transplantation - A Balancing Act.实体器官移植中的HLA配型策略——一种平衡行为
Front Immunol. 2016 Dec 7;7:575. doi: 10.3389/fimmu.2016.00575. eCollection 2016.